Skip to content
healthcare.dev

efavirenz 400 MG / lamivudine 300 MG / tenofovir disoproxil fumarate 300 MG Oral Tablet [Symfi]

RxNorm concept 2001430, branded drug (sbd). Prescribable name: Symfi Lo 400 MG / 300 MG / 300 MG Oral Tablet.

RxCUI
2001430
Term type
Branded drug (SBD)
Status
Active
Request
curl https://api.healthcare.dev/v1/drugs/rxnorm/2001430 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Concept

Ingredients and related concepts

Ingredients

Other names

Symfi Lo (efavirenz 400 MG / lamiVUDine 300 MG / tenofovir disoproxil fumarate 300 MG (equivalent to tenofovir disoproxil 245 MG)) Oral Tablet; Symfi Lo (efavirenz 400 MG / lamivudine 300 MG / tenofovir disoproxil fumarate 300 MG (equivalent to tenofovir disoproxil 245 MG)) Oral Tablet; efavirenz 400 MG / 3TC 300 MG / Tenofovir disoproxil fumarate 300 MG Oral Tablet [Symfi]; efavirenz 400 MG / lamiVUDine 300 MG / tenofovir disoproxil fumarate 300 MG Oral Tablet [Symfi]

Related concepts

Linked data

NDCs

  • 49502042593

NDC-11s RxNorm links to this concept; linked ones open their FDA product.

Use it

Look up 2001430 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/rxnorm/2001430 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up RxNorm concept 2001430. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.

Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.